The Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
The Department of Advanced Cardiology, The University of Tokyo, Toyo, Japan.
J Clin Endocrinol Metab. 2023 Nov 17;108(12):3145-3153. doi: 10.1210/clinem/dgad374.
There have been insufficient data on the threshold of body mass index (BMI) for developing diabetes mellitus (DM) and the relationship between change in BMI and the subsequent risk of DM.
We sought to clarify the association of BMI and its change with incident DM.
We conducted a retrospective observational cohort study using the JMDC Claims Database between 2005 and 2021. We included 3 400 303 individuals without a prior history of DM or usage of glucose-lowering medications. The median age was 44 years, and 57.5% were men. We categorized the study participants into 4 groups: underweight (BMI < 18.5 kg/m2), normal weight (BMI 18.5-24.9 kg/m2), overweight (BMI 25.0-29.9 kg/m2), and obese (BMI ≥ 30 kg/m2). According to the change in BMI from the initial health check-up to the health check-up 1 year after that, we divided the study participants into 3 groups: ≤-5.0%, -5.0% to +5.0%, and ≥+5.0%.
The risk of developing DM increased steeply after BMI exceeded approximately 20 to 21 kg/m2. Compared with participants with stable BMI (-5.0% to +5.0%), the relative risk for DM among those whose BMI had increased by 5.0% or more was 1.33 (95% CI 1.31-1.36). In contrast, the relative risk for DM among those whose BMI decreased by 5.0% or more was 0.82 (95% CI 0.80-0.84). Moreover, people classified as normal weight, overweight, and obese reduced the risk of developing DM when they reduced their BMI, whereas the risk of developing DM for people classified as underweight increased when they reduced their BMI.
Our findings offer novel insights into improving an optimal bodyweight management strategy to prevent the development of DM.
关于发展为糖尿病(DM)的体重指数(BMI)阈值以及 BMI 变化与 DM 后续风险之间的关系,数据仍不充分。
我们旨在阐明 BMI 及其变化与发生 DM 的关联性。
我们使用 2005 年至 2021 年期间的 JMDC 理赔数据库进行了一项回顾性观察性队列研究。我们纳入了 3400303 名无 DM 既往史或降糖药物使用史的个体。中位年龄为 44 岁,57.5%为男性。我们将研究参与者分为 4 组:体重不足(BMI<18.5kg/m2)、正常体重(BMI 18.5-24.9kg/m2)、超重(BMI 25.0-29.9kg/m2)和肥胖(BMI≥30kg/m2)。根据初始健康检查至健康检查后 1 年期间 BMI 的变化,我们将研究参与者分为 3 组:≤-5.0%、-5.0%至+5.0%和≥+5.0%。
BMI 超过约 20 至 21kg/m2 后,发展为 DM 的风险急剧增加。与 BMI 稳定(-5.0%至+5.0%)的参与者相比,BMI 增加 5.0%或更多的参与者发生 DM 的相对风险为 1.33(95%CI 1.31-1.36)。相比之下,BMI 减少 5.0%或更多的参与者发生 DM 的相对风险为 0.82(95%CI 0.80-0.84)。此外,BMI 降低的正常体重、超重和肥胖人群降低了发生 DM 的风险,而 BMI 降低的体重不足人群发生 DM 的风险增加。
我们的研究结果为制定改善最佳体重管理策略以预防 DM 提供了新的见解。